Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

May 6, 2020 Leave a comment 1,592 Views

Organicell Regenerative Medicine, Inc. a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Organicell

Organicell announces FDA approval of IND application for the treatment of SARS due to COVID-19

Upcoming Virtual Seminar – Stem Cell Extracellular Vesicles as a Holisitc Approach for CNS Repair

Reprogramming of MSCs to express neural markers using exosome treatments

Research on extracellular vesicle reversal of aging awarded NAM longevity challenge prize

Exosome Characterization Services to Better Define Characteristics of Exosome at Creative Biolabs

A promising new tool in the fight against melanoma

Emerging role of bacterial extracellular vesicles in cancer